PRCT
PROCEPT BioRobotics Corp
NASDAQ · Healthcare · Medical - Devices · US
$22.65
+12.30%Oct 2, 2026, 20:59 UTC
PROCEPT BioRobotics Corp appointed Dr. Michael Mack as a Class II director, effective October 2, 2026.
Sep 24, 2026, 20:48 UTC
PROCEPT BioRobotics Corp amended its loan and security agreement with Canadian Imperial Bank of Commerce, extending the term loan maturity date by 12 months to October 1, 2028, and paying a $26,000 extension fee.
Sep 22, 2026, 09:05 UTC
The DJS Law Group reminded investors of a class action lawsuit against PROCEPT BioRobotics Corporation alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5.
Source:Sep 21, 2026, 13:27 UTC
Johnson Fistel, PLLP announced it is investigating potential claims on behalf of long-term shareholders of PROCEPT BioRobotics Corporation against certain of its officers and directors for alleged breaches of fiduciary duty.
Source:Sep 17, 2026, 14:27 UTC
A class action complaint was filed on behalf of investors in PROCEPT BioRobotics, and Hagens Berman reminded investors of the September 22, 2026 lead plaintiff deadline.
Source:Sep 15, 2026, 17:15 UTC
The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of PROCEPT BioRobotics Corporation.
Aug 14, 2026, 19:37 UTC
A securities class action lawsuit has been filed against PROCEPT BioRobotics Corporation alleging federal securities law violations related to sales of its single-use handpiece and excess customer inventory levels.
Source:Aug 14, 2026, 15:30 UTC
Kaplan Fox & Kilsheimer LLP announced a securities class action deadline for PROCEPT BioRobotics Corporation investors, with the lead plaintiff deadline set for September 22, 2026.
Aug 4, 2026, 20:05 UTC
PROCEPT BioRobotics Corporation reported unaudited financial results for the quarter ended June 30, 2026.
Jul 31, 2026, 08:11 UTC
A class action lawsuit was filed against PROCEPT BioRobotics Corporation for alleged securities law violations under the Securities Exchange Act of 1934, and investors are being reminded of the case by the DJS Law Group.
Source:Jul 27, 2026, 15:57 UTC
A shareholder filed a securities class action lawsuit against PROCEPT BioRobotics Corporation on behalf of investors who purchased common stock between February 28, 2024 and February 25, 2026.
Jun 29, 2026, 00:00 UTC
Establishment Labs Holdings Inc. appointed Taylor Harris as a new director, effective June 24, 2026.